Cancer Therapeutics Market Revenue 2025 to 2034
Cancer Therapeutics Market Revenue 2025 to 2034
Cancer Therapeutics Market (By Application: Blood Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Breast Cancer, Cervical Cancer, Head and Neck Cancer, Glioblastoma, Malignant Meningioma, Mesothelioma, Melanoma, and Others; By Top Selling Drugs; By End User: Hospitals, Specialty Clinics, and Cancer & Radiation Therapy Centers; By Region: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa) Industry Size, Share, Growth, Trends 2025 to 2034.
Customisation Request
Revenue, 2025
USD 212.58 Bn
Forecast Year, 2034
USD 469.38 Bn
CAGR, 2025 - 2034
9.20%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global cancer therapeutics market is experiencing robust growth, driven by rising cancer prevalence, advances in targeted therapies, and increasing R&D investments. Valued at USD 212.58 billion in 2025, the market is projected to reach USD 469.38 billion by 2034, expanding at a CAGR of 9.20%.
Cancer Therapeutics Market Size Analysis
Cancer Therapeutics Market Size By Application 2025 to 2034 (USD Billion)
| Application | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Blood Cancer | 38.26 | 41.81 | 45.67 | 49.90 | 54.51 | 59.56 | 65.07 | 71.09 | 77.66 | 84.85 |
| Lung Cancer | 34.01 | 37.20 | 40.68 | 44.49 | 48.65 | 53.20 | 58.18 | 63.62 | 69.57 | 76.08 |
| Colorectal Cancer | 21.26 | 23.20 | 25.32 | 27.64 | 30.17 | 32.92 | 35.94 | 39.22 | 42.81 | 46.72 |
| Prostate Cancer | 19.13 | 20.88 | 22.79 | 24.88 | 27.15 | 29.63 | 32.34 | 35.30 | 38.53 | 42.05 |
| Breast Cancer | 29.76 | 32.52 | 35.52 | 38.81 | 42.40 | 46.32 | 50.61 | 55.29 | 60.40 | 65.99 |
| Cervical Cancer | 10.63 | 11.59 | 12.64 | 13.78 | 15.02 | 16.38 | 17.86 | 19.48 | 21.24 | 23.16 |
| Head and Neck Cancer | 12.75 | 13.91 | 15.16 | 16.53 | 18.03 | 19.66 | 21.43 | 23.37 | 25.48 | 27.79 |
| Glioblastoma | 10.63 | 11.60 | 12.66 | 13.82 | 15.08 | 16.46 | 17.97 | 19.61 | 21.40 | 23.36 |
| Malignant Meningioma | 8.50 | 9.28 | 10.13 | 11.06 | 12.07 | 13.17 | 14.37 | 15.69 | 17.12 | 18.69 |
| Mesothelioma | 6.38 | 6.95 | 7.58 | 8.27 | 9.01 | 9.83 | 10.72 | 11.69 | 12.74 | 13.89 |
| Melanoma | 12.75 | 13.94 | 15.22 | 16.63 | 18.17 | 19.85 | 21.69 | 23.70 | 25.89 | 28.28 |
| Others | 8.50 | 9.27 | 10.11 | 11.02 | 12.02 | 13.10 | 14.29 | 15.58 | 16.99 | 18.52 |
Cancer Therapeutics Market Size By End User 2025 to 2034 (USD Billion)
| End User | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | 116.92 | 127.47 | 138.97 | 151.52 | 165.19 | 180.10 | 196.36 | 214.08 | 233.40 | 254.46 |
| Specialty Clinics | 42.52 | 46.49 | 50.84 | 55.60 | 60.79 | 66.48 | 72.70 | 79.49 | 86.93 | 95.05 |
| Cancer and Radiation Therapy Centers | 53.14 | 58.17 | 63.68 | 69.70 | 76.29 | 83.51 | 91.41 | 100.05 | 109.51 | 119.87 |
Cancer Therapeutics Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 89.28 | 97.26 | 105.96 | 115.43 | 125.74 | 136.98 | 149.22 | 162.55 | 177.08 | 192.90 |
| Asia Pacific | 63.77 | 69.89 | 76.59 | 83.94 | 91.99 | 100.81 | 110.47 | 121.05 | 132.65 | 145.36 |
| Europe | 42.52 | 46.36 | 50.56 | 55.13 | 60.12 | 65.56 | 71.49 | 77.95 | 85.01 | 92.70 |
| LAMEA | 17.01 | 18.62 | 20.38 | 22.32 | 24.43 | 26.75 | 29.29 | 32.06 | 35.10 | 38.43 |
Cancer Therapeutics Market Size to Attain USD 469.38 Billion by 2034
The cancer therapeutics market size accounted for USD 212.58 billion in 2025 and is predicted to touch around USD 469.38 billion by 2034 at a CAGR of 9.20%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
